phenytoin has been researched along with Cardiac Conduction Defect in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gando, I | 1 |
| Campana, C | 1 |
| Tan, RB | 1 |
| Cecchin, F | 1 |
| Sobie, EA | 1 |
| Coetzee, WA | 1 |
| SCHERF, D | 1 |
| BLUMENFELD, S | 1 |
| TANER, D | 1 |
| YILDIZ, M | 1 |
2 other studies available for phenytoin and Cardiac Conduction Defect
| Article | Year |
|---|---|
A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Topics: Action Potentials; Amino Acid Substitution; Anti-Arrhythmia Agents; Cardiac Conduction System Diseas | 2020 |
The effect of diphenylhydantoin (Dilantin) sodium on atrial flutter and fibrillation provoked by focal application of a conitine or delphinine.
Topics: Alkaloids; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Cond | 1960 |